New Anemia Pill In The Works
Akebia and Fibrogen are both vying to treat chronic kidney disease patients—including dialyzors who suffer from anemia—with a pill. If approved, the drugs will take aim at replacing less convenient, injectable anemia drugs like Amgen's Epogen.
Read the full article » | Posted 01-10-2016
Related Articles
- University of North Carolina’s GENESIS project to make HD device the size of a cell phone Posted 09-12-2024
- Kamal Shah of NephroPlus Discusses Dalysis Innovations Posted 08-16-2024
- Global Wearable Artificial Kidney Market Expected to Grow Posted 07-12-2024
- Byonyks X1: a New, Small, Portable APD Machine Posted 06-14-2024